clinivation

  • Sign In
  • Contact
  • About
    • What We Do
    • Newsroom
    • Our Partners
    • Events
    • Careers
    • Contact
  • Solutions
    • Business Development
    • Clinical Operations
    • Commercial Operations
    • Health Policy & Reimbursement
    • Medical Affairs
    • Portfolio Management
    • Regulatory Affairs
    • Research & Development
  • Products
    • CareSite
    • ClinicalSuite
    • Cloud
    • Conformity
    • ForeSight
    • Global
    • Prospectus
    • RealWorld
    • RegistrySuite
    • ValueLogic
    • WorldView
  • Services & Support
    • Customer Support
    • Solution Services
    • CRO Services
    • Professional Services
    • Innovation Workshops
  • Resources
    • Data Sheets
  • Customers
    • Customer Success
Home / News / Clinivation Founder and CEO Joseph Kozikowski, M.D. to Present at Expert Conferences
clinivation
CONTACT US

Clinivation Founder and CEO Joseph Kozikowski, M.D. to Present at Expert Conferences

Dr. Joseph Kozikowski will present on corporate governance and regulatory affairs at the Expert Conferences online event.

NATICK, MA – June 6, 2009 – Clinivation, Inc. announced today that clinivation Founder and CEO Joseph Kozikowski, M.D. will present at the Expert Conferences Event online.

As an authority on the development and commercialization of advanced medical technology, as a Certified Director, and having led thousands of new submissions, renewals, refilings, novated submissions for major multinationals worldwide, Dr. Kozikowski will share his perspectives in a presentation entitled “Effective Governance of Global Market Clearance Operations.”

The presentation will address innovative approaches and important industry best practices, and will include discussions on value creation, effective governance, and enabling execution with information technology.

More specifically, Dr. Kozikowski will present how contemporary corporate governance has direct purview over global market clearance operations. Indeed, achieving sustainable compliance with Sections 302, 404, and 406 of the Sarbanes-Oxley Act requires executives to establish and test controls for management visibility, provide governance of export compliance, and effect management sign-off on a code of ethics that mandates compliance with all “applicable governmental rules and regulations.”

And because companies must report related deficiencies, companies are now disclosing export control deficiencies in their annual 10K securities filings. New SEC “disclosure reform” and “shareholder rights” legislation are creating additional requirements for managing market clearance operational compliance and risk.

In this presentation, he will also examine how effective governance is enabled by gaining visibility on the entire process and status of global market clearance operations, delivering comprehensive regulatory intelligence into day-to-day activities, and integrating of automated, clearance-driven business controls into selling, production, and shipping processes. He will also discuss how achieving effective governance and sustainable compliance creates enterprise value.

The audience will include industry regulatory affairs, legal, and other executive leadership. The presentation will be held in conjunction with the Pharmaceutical Regulatory Expert Series conferences on June 16, 2009 at the Expert Conferences Event online.

Following the presentation, Dr. Kozikowski will be available for discussions and meetings to discuss the topics in greater depth.

Quotes & Commentary:

“It is an honor to have been invited to present, and I thank the Expert Conferences leadership for their efforts in arranging this opportunity for international learning,” said clinivation Founder and CEO Joseph Kozikowski, M.D.

About Expert Conferences:

Expert Conferences delivers specialized professional education to the life sciences industry.

Expert Conferences is based in Sacramento, CA.

Share

About clinivation

Clinivation solutions deliver the digital advantage to outperform in new business environments with innovative and better ways to succeed in global development and commercialization.

Our cross‐functional software brings people and knowledge to the point of action to eliminate revenue traps, overcome process complexity, and enable execution with full visibility, decision support, and controls.

Trusted for millions of products by hundreds of companies worldwide, our modular, interoperating applications yield new, scalable operating models that directly connect biomedical innovation with high‐value inflection points and business growth.

The world’s leading medtech, pharmaceutical, and biotech organizations partner with clinivation because of our industry expertise and our transformative solutions that seamlessly integrate existing business processes and enterprise infrastructure‐ leveraging cloud, hybrid, and on‐premises architectures.

Our vision is to inspire our shared purpose of bringing innovation to life with the value of information technology.

Media Contact

Corporate Communications
irpr@clinivation.com

clinivation, Inc.
Suite 1800
245 First Street
Cambridge, MA 02142
U.S.A.
Phone +1 617‐444‐8500

About

  • What We Do
  • Newsroom
  • Our Partners
  • Events
  • Careers
  • Contact

Solutions

  • Business Development
  • Clinical Operations
  • Commercial Operations
  • Health Policy & Reimbursement
  • Medical Affairs
  • Portfolio Management
  • Regulatory Affairs
  • Research & Development

Products

  • CareSite
  • ClinicalSuite
  • Cloud
  • Conformity
  • ForeSight
  • Global
  • Prospectus
  • RealWorld
  • RegistrySuite
  • ValueLogic
  • WorldView

Services & Support

  • Customer Support
  • Solution Services
  • CRO Services
  • Professional Services
  • Innovation Workshops

Resources

  • Data Sheets

Customers

  • Customer Success
American Flag US: +1 (617) 444‐8500
Contact Us
  • Privacy
  • Terms Of Use
  • Trademarks
  • Site Map

© 2025 · clinivation, INC.

Clinivation solutions deliver the digital advantage to outperform in new business environments with innovative and better ways to succeed in global development and commercialization.

Our cross‐functional software brings people and knowledge to the point of action to eliminate revenue traps, overcome process complexity, and enable execution with full visibility, decision support, and controls.

Trusted for millions of products by hundreds of companies worldwide, our modular, interoperating applications yield new, scalable operating models that directly
connect biomedical innovation with high‐value inflection points and business growth.

The world’s leading medtech, pharmaceutical, and biotech organizations partner with clinivation because of our industry expertise and our transformative solutions
that seamlessly integrate existing business processes and enterprise infrastructure‐ leveraging cloud, hybrid, and on‐premises architectures.

Our vision is to inspire our shared purpose of bringing innovation to life with the value of information technology.

​